|1.||Feng, Si-Shen: 9 articles (03/2014 - 07/2006)|
|2.||Zhang, Zhiping: 4 articles (01/2013 - 07/2006)|
|3.||Sun, Leilei: 3 articles (09/2014 - 01/2013)|
|4.||Tang, Xiaolong: 3 articles (01/2014 - 01/2013)|
|5.||Zheng, Yi: 2 articles (09/2014 - 01/2013)|
|6.||Zhao, Jing: 2 articles (03/2014 - 10/2012)|
|7.||Zhang, Rongbo: 2 articles (01/2014 - 01/2013)|
|8.||Ding, Jun: 2 articles (10/2012 - 04/2011)|
|9.||Gan, Chee Wee: 2 articles (07/2009 - 08/2008)|
|10.||Lee, Sie Huey: 2 articles (08/2008 - 04/2007)|
|1.||Lung Neoplasms (Lung Cancer)
03/01/2014 - "The reduction of anti-cancer drug antagonism by the spatial protection of drugs with PLA-TPGS nanoparticles."
08/01/2008 - "The PLA-TPGS NP formulation can realize a way of controlled and sustained drug release for more than 10 days, which relieves one of the two major concerns on cancer nanotechnology, i.e. "
07/01/2006 - "However, the PLA-TPGS NPs of 89:11 PLA:TPGS ratio achieved the best effects on the drug encapsulation efficiency, the cellular uptake and the cancer cell mortality of the drug-loaded PLA-TPGS NPs. "
07/01/2006 - "Cancer cell viability of the drug-loaded PLA-TPGS was measured by MTT assay. "
07/01/2006 - "Cancer cell lines HT-29 and Caco-2 were used to image and measure the cellular uptake of fluorescent PLA-TPGS NPs. "
|3.||Breast Neoplasms (Breast Cancer)
04/01/2011 - "The cellular uptake and the cytotoxicity of the PLA-TPGS NPs formulation of QDs and IOs were investigated in vitro with MCF-7 breast cancer cells, which were conducted in close comparison with the free QDs and IOs at the same agent dose. "
01/01/2013 - "In conclusion, such nanoparticles of star-shaped cholic acid-core PLA-TPGS block copolymer could be considered as a potentially promising and effective strategy for breast cancer treatment. "
10/11/2010 - "We first found that the activity of P-glycoprotein in drug-resistant breast cancer MCF-7/ADR cells was decreased after incubation with PLA-TPGS nanoparticles. "
01/01/2013 - "Paclitaxel-loaded nanoparticles of star-shaped cholic acid-core PLA-TPGS copolymer for breast cancer treatment."
02/01/2009 - "Additionally, our findings indicated that under same conditions, cytotoxicity of QDs formulated in the PLA-TPGS/TPGS-COOH NPs is lower for normal cells such as NIH 3T3 cells than that for breast cancer such as MCF-7 breast cancer cells due to folate targeting effect. "
|4.||Prostatic Neoplasms (Prostate Cancer)
09/01/2014 - "In summary, the star-like copolymer M-PLA-TPGS could be used as a potential and promising molecular biomaterial in developing novel nanoformulation for prostate cancer treatment."
09/01/2014 - "The purpose of this research was to develop novel nanoparticles (NPs) of star-like copolymer mannitol-functionalized poly(lactide)-vitamin E TPGS (M-PLA-TPGS) for paclitaxel delivery for prostate cancer treatment, and evaluate their therapeutic effects in prostate cancer cell line and animal model in comparison with the linear PLGA NPs and poly(lactide)-vitamin E TPGS (PLA-TPGS) NPs. "
10/01/2012 - "We developed a system of nanoparticles of poly(lactide)-d-α-tocopheryl polyethylene glycol succinate (PLA-TPGS) and carboxyl group-terminated TPGS (TPGS-COOH) copolymer blend for multimodality treatment of cancer, which formulated docetaxel for chemotherapy, herceptin for biotherapy and targeting, and iron oxides (IOs) for hyperthermia therapy, which are denoted as MMNPs. "
|1.||Succinic Acid (Succinate)
|2.||Polyethylene Glycols (Polyethylene Glycol)
|4.||alpha-tocopheryl polyethylene glycol succinate
|5.||polylactic acid-polyglycolic acid copolymer (PLGA)
|6.||Folic Acid (Vitamin M)
|1.||Heterologous Transplantation (Xenotransplantation)
|4.||Drug Therapy (Chemotherapy)